What you'll learn

  • The importance of testosterone in male health

  • Testosterone therapy in women

  • The ABCs of testosterone

  • Can testosterone be used in men with prostate cancer?

  • Testosterone and the risk of breast cancer in women

  • Reducing risks, including cardiovascular disease

Course description

Testosterone therapy is one of the most controversial topics in medicine, yet multiple medical societies endorse its use, supported by level 1 evidence showing a variety of health benefits in men and women. This innovative and comprehensive course will focus on testosterone deficiency and its treatment in men and women and will also address several other sexual issues. Studies indicate that nearly 40% of men over the age of 45 have overtly low testosterone levels, yet education in this area is extremely limited. Similarly, there have been few educational opportunities to address sexual dysfunction in men and women. Approximately 40% of men and a similar percentage in women have one sexual dysfunction or another. Indeed, there have been several fascinating therapeutic advances in the treatment of sexual dysfunction in women that have received scant attention in other educational events.

The course is led by men’s health pioneer Abraham Morgentaler, MD, whose research in the field transformed our understanding of the science of testosterone in men. Dr. Morgentaler has assembled as all-star faculty of thought leaders to address the most relevant issues and controversies, demystify the topic with science and clinical experience and provide an evidence-based approach to treatment. The course will also address management of several common sexual problems for men, including erectile dysfunction and Peyronie’s disease, and will also address several common sexual issues for women, including hypoactive sexual desire disorder. A clinical psychologist and sex therapist will explore non-medical strategies for managing couples with sexual complaints. This accredited course is offered by Beth Israel Deaconess Medical Center. Contact ceprograms@hms.harvard.edu with questions. 

Register before January 6, 2023 for discounted pricing. 

You may also like

In-Person

This course will outline the National Comprehensive Cancer Network’s (NCCN) accepted guidelines, and highlight updates to staging, treatment and indications for neoadjuvant and adjuvant therapy.

Price
$50 - $150
Registration Deadline
Starts Apr 11